Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field-Reference-Cited by-同舟云学术

Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field

Published:2017-07-03 Issue:3 Volume:15 Page:
ISSN:1570-162X
Container-title:Current HIV Research
language:en
Short-container-title:CHR

Author:

Wines Bruce D.¹,Billings Hugh¹,Mclean Milla R.²,Kent Stephen J.³,Hogarth P. Mark⁴

Affiliation:

1. Centre for Biomedical Research, Burnet Institute, Melbourne, Vic 3004, Australia

2. Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Parkville, Victoria, Australia

3. ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Parkville, Victoria, Australia

4. Centre for Biomedical Research, Burnet Institute, 85 Commercial Road, Melbourne, VIC 3004, Australia

Publisher

Bentham Science Publishers Ltd.

Subject

Virology,Infectious Diseases

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrimer-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

2. HIV-1 Vpu restricts Fc-mediated effector functions in vivo;2022-02-22

3. Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV;Vaccines;2021-11-05

4. Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response;WIREs Nanomedicine and Nanobiotechnology;2021-08-19

5. The COVID-19 Vaccine Landscape;Advances in Experimental Medicine and Biology;2021